Brought to you by 
Savara brings in $833k so far through its Series A round; exceeds $1.4mm
19 Jun 2012
Executive Summary
Savara (pulmonary drug delivery) has raised at least $833k of a proposed $1.4mm Series A venture round. There were 13 investors, most of whom are current shareholders. A second tranche may close later this year.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Pulmonary
-
Drug Delivery
-
Biotechnology
- Nanotechnology, Chips, etc.
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Savara brings in $833k so far through its Series A round; exceeds $1.4mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice